Advertisement
Singapore markets close in 3 hours 11 minutes
  • Straits Times Index

    3,280.23
    -12.90 (-0.39%)
     
  • Nikkei

    37,636.69
    -823.39 (-2.14%)
     
  • Hang Seng

    17,279.87
    +78.60 (+0.46%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Bitcoin USD

    64,349.44
    -2,328.47 (-3.49%)
     
  • CMC Crypto 200

    1,386.86
    -37.24 (-2.62%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,329.40
    -9.00 (-0.38%)
     
  • Crude Oil

    82.97
    +0.16 (+0.19%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,570.29
    -1.19 (-0.08%)
     
  • Jakarta Composite Index

    7,157.23
    -17.30 (-0.24%)
     
  • PSE Index

    6,580.42
    +7.67 (+0.12%)
     

This Biotech Stock Just Pushed Back A Key Trial Until Early 2018

This Biotech Stock Just Pushed Back A Key Trial Until Early 2018

Intercept will push a Phase 3 study of its liver disease drug, Ocaliva, in cirrhotic nonalcoholic steatohepatitis into the first quarter, an analyst said Thursday.